OPERF
CTKB icon

Oregon Public Employees Retirement Fund’s Cytek Biosciences CTKB Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25,175
Closed -$110K – 1519
2026
Q1 		$110K Hold
25,175
– – ﹤0.01% 1497
2025
Q4 		$127K Buy
25,175
+500
+2% +$2.32K ﹤0.01% 1478
2025
Q3 		$85.6K Buy
24,675
+1,200
+5% +$4.5K ﹤0.01% 1504
2025
Q2 		$79.8K Sell
23,475
-475
-2% -$1.58K ﹤0.01% 1500
2025
Q1 		$96K Sell
23,950
-600
-2% -$3.11K ﹤0.01% 1497
2024
Q4 		$159K Sell
24,550
-500
-2% -$2.98K ﹤0.01% 1452
2024
Q3 		$139K Buy
25,050
+1,800
+8% +$10.2K ﹤0.01% 1473
2024
Q2 		$130K Sell
23,250
-3,200
-12% -$19.2K ﹤0.01% 1470
2024
Q1 		$177K Sell
26,450
-2,500
-9% -$19.8K ﹤0.01% 1443
2023
Q4 		$264K Sell
28,950
-500
-2% -$3.15K ﹤0.01% 1398
2023
Q3 		$163K Buy
29,450
+4,500
+18% +$36.1K ﹤0.01% 1606
2023
Q2 		$213K Buy
+24,950
New +$224K ﹤0.01% 1575

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Oregon Public Employees Retirement Fund's CTKB Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund sold out of Cytek Biosciences (CTKB) in Q2 2026, closing a stake of 25,175 shares — an estimated $110K sold.

Oregon Public Employees Retirement Fund first reported a position in CTKB in Q2 2023 and held it in 12 quarters. The position peaked at $264K in Q4 2023. 154 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Oregon Public Employees Retirement Fund reported no remaining Cytek Biosciences position as of Q2 2026 after selling out during the quarter.
  • Oregon Public Employees Retirement Fund sold 25,175 Cytek Biosciences shares in Q2 2026, an estimated $110K.
  • Oregon Public Employees Retirement Fund first reported a position in Cytek Biosciences in Q2 2023 and held it in 12 quarters.
  • Oregon Public Employees Retirement Fund's Cytek Biosciences position peaked at $264K in Q4 2023.
  • 154 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.